Target intelligence / Profile preview

Poliovirus Type 1/2/3 Antigen (Poliovirus 1/2/3 Antigen)

Target
Poliovirus 1/2/3 Antigen
Molecular classification
Viral protein, Capsid protein, Antigen
01

Overview

The poliovirus type 1/2/3 antigen refers to the structural proteins (antigens) present on the surface of the three serotypes of poliovirus: type 1, type 2, and type 3. These antigens are primarily responsible for eliciting an immune response and are critical components in both inactivated (IPV) and oral (OPV) polio vaccines. They are not therapeutic targets in themselves, but rather components used to elicit an immune response.

Other names
Poliovirus capsid proteinPV1 antigenPV2 antigenPV3 antigenPoliovirus structural proteins
02

Mechanism of action

N/A

03

Biological functions

Eliciting immune responseViral entryAntigen presentation
04

Disease associations

PoliomyelitisAcute flaccid paralysisVaccine development
05

Safety considerations

Vaccine-derived poliovirus (VDPV) circulationPotential for reversion to virulence in OPV
06

Interacting drugs

Formaldehyde

2 more in the full profile.

Beyond the preview

Go deeper on Poliovirus Type 1/2/3 Antigen (Poliovirus 1/2/3 Antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poliovirus Type 1/2/3 Antigen (Poliovirus 1/2/3 Antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call